Micropores enhance organ-on-chip models for studying hidden infections
November 18, 2025
A new study provides a powerful way to study infections in environments that closely mimic human organs.
A new study provides a powerful way to study infections in environments that closely mimic human organs.
Our body’s “blood factory” consists of specialized tissue made up of bone cells, blood vessels, nerves and other cell types. Now, researchers have succeeded for the first time in recreating this cellular complexity in the laboratory using only human cells. The novel system could reduce the need for animal experiments for many applications.
Humans can “catch” fear from robots, new research has shown. The findings—by a team of psychologists from the University of Amsterdam and the University of British Columbia—shed new light on how emotions can spread through touch, with implications for human relationships, mental health, and future technologies such as virtual reality and wearable devices.
For the first time, scientists have grown functional, brain-like tissue without using any animal-derived materials or added biological coatings. The development opens the door to more controlled and humane neurological drug testing.
Philips (NYSE: PHG)+ today announced the introduction of DeviceGuide, an AI-powered tracking solution for interventional cardiology.
Neocis announced today that it launched Yomi S, its next-generation robotic platform for dental implant surgery.
1nhaler announced today that it secured approximately $2 million (£1.5 million) in seed funding to support its inhaler technology.
Competing with companies including Stryker and J&J, Zimmer has moved to strengthen its position by developing an updated robot.
RALEIGH, N.C., Nov. 17, 2025 /PRNewswire/ — Arctx Medical, Inc. (“Arctx,” “the Company”), a clinical-stage medical device company, announced today that it has achieved two additional significant milestones:
A new artificial intelligence tool that can create virtual representations of patients and predict individual health trajectories has been hailed a potential gamechanger for the clinical trial sector.